Early research suggests the decades-old diabetes drug metformin can slow cancer, reduce heart disease and perhaps limit the ravages of Alzheimer's. A new study shows it can extend lifespan in mice. Research by David Sinclair, HMS professor of genetics, and Kevin Struhl, the David Wesley Gaiser Professor of Biological Chemistry and Molecular Pharmacology, is cited.